• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Vanda Pharmaceuticals Inc

+ Add to Watchlist

VNDA:US

11.9700 USD 0.2300 1.89%

As of 13:58:48 ET on 01/27/2015.

Snapshot for Vanda Pharmaceuticals Inc (VNDA)

Open: 12.0900 Day's Range: 11.8100 - 12.2099 Volume: 668,928
Previous Close: 12.2000 52wk Range: 8.3350 - 19.2500 1-Yr Rtn: -3.70%

Stock Chart for VNDA

No chart data available.
  • VNDA:US 11.9600
  • 1D
  • 1M
  • 1Y
12.2000
Interactive VNDA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VNDA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.7000
Est. EPS (USD) (12/2014) -1.1650
Est. PEG Ratio -
Market Cap (M USD) 478.59
Shares Outstanding (M) 39.65
30 Day Average Volume 856,100
Price/Book (mrq) 383.0217
Price/Sale (ttm) 9.2940
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VNDA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for VNDA

Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.

Mihael H PolymeropoulosPresident/CEO/Co-FounderJames Patrick Kelly "Jim"Senior VP/CFO/Treasurer/Secy
Paolo BaroldiSenior VP/Chief Medical Officer
More Company Profile & Key Executives for VNDA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil